SCHEMBL29906830

SCHEMBL29906830

CCOc1cc2[nH]nc(-c3cnn(C)c3)c2nc1-c1cccc2c1CCC2

nearest known ligand 0.45

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TTK P33981 2/20 0.45
MAPK8 P45983 2/20 0.45
MAP4K1 Q92918 3/20 0.44
FGFR1 P11362 2/20 0.43
ACVR1 Q04771 2/20 0.43
FGFR2 P21802 1/20 0.43
FGFR3 P22607 5/20 0.42
PIM1 P11309 6/20 0.41
WNT1 P04628 1/20 0.39
AXL P30530 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23210780 1.00 TTK (0.45) TTKMAPK8MAP4K1FGFR1ACVR1
SCHEMBL23210998 0.90 FGFR3 (0.50) MAP4K1FGFR1ACVR1FGFR2FGFR3
SCHEMBL29906953 0.90 FGFR3 (0.50) MAP4K1FGFR1ACVR1FGFR2FGFR3
SCHEMBL29906904 0.86 MAP4K1 (0.46) MAP4K1FGFR1ACVR1FGFR2FGFR3
SCHEMBL23210991 0.86 MAP4K1 (0.46) MAP4K1FGFR1ACVR1FGFR2FGFR3
SCHEMBL23264007 0.84 FGFR3 (0.49) MAP4K1FGFR1ACVR1FGFR2FGFR3
SCHEMBL29906910 0.84 MAP4K1 (0.48) MAP4K1FGFR1ACVR1FGFR2FGFR3
SCHEMBL23211068 0.84 MAP4K1 (0.48) MAP4K1FGFR1ACVR1FGFR2FGFR3
SCHEMBL23211047 0.83 MAP4K1 (0.46) MAP4K1FGFR1ACVR1FGFR2FGFR3
SCHEMBL29906913 0.83 MAP4K1 (0.46) MAP4K1FGFR1ACVR1FGFR2FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115835908-A Bicyclic heterocycles as FGFR inhibitors 因赛特公司 2023-03-21 CN claimed
EP-4045151-A1 BICYCLIC HETEROCYCLES AS FGFR INHIBITORS Incyte Corporation (US) 2022-08-24 EP claimed
CN-115835908-A Bicyclic heterocycles as FGFR inhibitors 因赛特公司 2023-03-21 CN disclosed
EP-4045151-A1 BICYCLIC HETEROCYCLES AS FGFR INHIBITORS Incyte Corporation (US) 2022-08-24 EP disclosed